In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer
about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionNKG2D ligands as therapeutic targetsCrystal Structure of the Cowpox Virus-Encoded NKG2D Ligand OMCPPrenylated Polyphenols from Clusiaceae and Calophyllaceae with Immunomodulatory Activity on Endothelial CellsGenetic Diversity and mRNA Expression of Porcine MHC Class I Chain-Related 2 (SLA-MIC2) Gene and Development of a High-Resolution Typing MethodMHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue.NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patientsGenetics, genomics, and evolutionary biology of NKG2D ligands.TLR and NKG2D signaling pathways mediate CS-induced pulmonary pathologiesAssociation of MICA-TM and MICB C1_2_A microsatellite polymorphisms with tumor progression in patients with colorectal cancer.Association of MICA with rheumatoid arthritis independent of known HLA-DRB1 risk alleles in a family-based and a case control studyNKG2D ligands in tumor immunity.Proteasome regulation of ULBP1 transcription.Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy CellsNatural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation.Effect of NKG2D ligand expression on host immune responsesEthanol-dependent expression of the NKG2D ligands MICA/B in human cell lines and leukocytes.Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation.Post-translational modification of the NKG2D ligand RAET1G leads to cell surface expression of a glycosylphosphatidylinositol-linked isoformA new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA.MICA*A4 protects against ulcerative colitis, whereas MICA*A5.1 is associated with abscess formation and age of onset.NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migrationAnti-NKG2D mAb: A New Treatment for Crohn's Disease?New twist on the regulation of NKG2D ligand expression.New prospects on the NKG2D/NKG2DL system for oncology.Allele Specific Expression of MICA Variants in Human Fibroblasts Suggests a Pathogenic Mechanism.Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.High diversity of MIC genes in non-human primates.Positive association of major histocompatibility complex class I chain-related gene A polymorphism with leukemia susceptibility in the people of Han nationality of Southern China.The Paradoxical Role of NKG2D in Cancer Immunity
P2860
Q21131219-407A3668-1C3C-4CCF-9DC2-C2615F920143Q27014888-BCB7BFDD-BDA2-4E5D-8F59-23AA9580171AQ27674864-7BA72051-873A-42C3-BE30-345662F29D98Q28554642-8888C3E3-888A-48E8-A3C0-AF2A1419CEB3Q28608464-4DADF067-913B-4D26-91BB-652A4A6EE4A4Q33639723-B58696CC-4D74-4AB1-B8F2-DB618CF4F30DQ33816779-ED53E721-FAA4-4BAD-ACBA-AA900152A119Q34488774-84353144-D83D-4448-B798-32125A153A33Q34489980-84803C22-80DE-450F-8793-B8437AF5F4E9Q35018946-1514AEBE-CD9A-4AC1-A1C5-080B47118784Q37241707-DDA462E6-DED3-46B2-ADBD-BC3969CB1565Q37270736-A77310C9-3BFF-4FD3-A7AD-50E8000C8108Q37287179-7AD107F0-5859-4D7C-8985-03609FE0BC07Q37357720-E380C79E-B65D-460D-BBE2-3109785AE650Q37559284-BDF315DE-2FC7-4949-A57D-C4E0B1107497Q37721591-D7A7AD9F-9E8E-4AC8-A8FE-E0AD2CB475ECQ37764003-A6B2A490-FBC8-4F9A-BD28-5230484E7684Q38717349-471E349B-C332-43AD-BAAC-54718D432137Q38940720-8321736C-7325-4EDC-A85E-9510C43C2E15Q39011291-806398CF-41FA-4354-8CE3-ADD96B69DB76Q39178552-C596B3CB-7CF3-4225-8A21-B4AF839263C6Q39725225-B3DD922B-EA45-4916-A78A-F2B12693F1C0Q40257100-CE408392-AEF1-4D54-8D1A-4954E6780548Q40768509-41A0D9B1-582E-45D7-BE0C-D363A0BD8A06Q41442867-640E7F2E-EA34-407B-8CD4-A6FBD5D3FB6CQ41660377-22269439-4FC6-4C2D-963A-8B87B5B493C2Q42136711-A8781B50-C085-49F0-9B70-ACD160CFDC4BQ42796257-603363B1-AE7B-4626-8AA0-1B136648C39EQ42905223-32E506BA-2216-4D37-A2A5-B3C09977580FQ47671726-8639A90F-8265-4B27-B525-2D096F6D72EFQ52836407-3ADD8C0E-F9D0-4DE7-8584-6E668063F0DCQ54356152-FAE065C8-C1AA-47E3-B3DA-FE04B9FBB0C4Q58785685-7732C098-1DE5-499D-9B56-6ACAD4ADFA21
P2860
In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer
@ast
In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer
@en
type
label
In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer
@ast
In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer
@en
prefLabel
In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer
@ast
In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer
@en
P2093
P2860
P1433
P1476
In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer
@en
P2093
Jean Sibilia
Marc Ardizzone
Stéphanie Schrambach
Vincent Leymarie
P2860
P356
10.1371/JOURNAL.PONE.0000518
P407
P577
2007-06-13T00:00:00Z